Our Science Focus

Our research into new medicines is focused on those of areas of science with significant medical need and where we continue to innovate and lead the science. We are concentrating our research efforts and investment in: CardioMetabolic diseases; Central Nervous System diseases; Immunology and Respiratory diseases; Oncology and Cancer Immunology and Retinal health. Our scientists are also contributing to the collective effort to fight COVID-19.

Our U.S. Innovation Hub

Our U.S. headquarters in Ridgefield, Conn. is home to one of Boehringer Ingelheim’s leading research and development sites with expertise across research, development and translational medicine and clinical pharmacology.